Literature DB >> 23552953

Dissecting the genotype in syndromic intellectual disability using whole exome sequencing in addition to genome-wide copy number analysis.

Carl Friedrich Classen1, Vera Riehmer, Christina Landwehr, Anne Kosfeld, Stefanie Heilmann, Caroline Scholz, Sarah Kabisch, Hartmut Engels, Sascha Tierling, Miroslav Zivicnjak, Frank Schacherer, Dieter Haffner, Ruthild G Weber.   

Abstract

When a known microimbalance affecting multiple genes is detected in a patient with syndromic intellectual disability, it is usually presumed causative for all observed features. Whole exome sequencing (WES) allows questioning this assumption. In this study of three families with children affected by unexplained syndromic intellectual disability, genome-wide copy number and subsequent analyses revealed a de novo maternal 1.1 Mb microdeletion in the 14q32 imprinted region causing a paternal UPD(14)-like phenotype, and two inherited 22q11.21 microduplications of 2.5 or 2.8 Mb. In patient 1 carrying the 14q32 microdeletion, tall stature and renal malformation were unexplained by paternal UPD(14), and there was no altered DLK1 expression or unexpected methylation status. By WES and filtering with a mining tool, a novel FBN1 missense variant was found in patient 1 and his mother, who both showed clinical features of Marfan syndrome by thorough anthropometric assessment, and a novel EYA1 missense variant as a probable cause of the renal malformation in the patient. In patient 2 with the 22q11.21 microduplication syndrome, skin hypo- and hyperpigmentation and two malignancies were only partially explained. By WES, compound heterozygous BLM stop founder mutations were detected causing Bloom syndrome. In male patient 3 carrying a 22q11.21 microduplication inherited from his unaffected father, WES identified a novel missense variant in the OPHN1 X-linked intellectual disability gene inherited from the unaffected mother as a possible additional cause for developmental delay. Thus, WES seems warranted in patients carrying microdeletions or microduplications, who have unexplained clinical features or microimbalances inherited from an unaffected parent.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23552953     DOI: 10.1007/s00439-013-1296-1

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  46 in total

1.  Mutation screening of the EYA1, SIX1, and SIX5 genes in a large cohort of patients harboring branchio-oto-renal syndrome calls into question the pathogenic role of SIX5 mutations.

Authors:  Pauline Krug; Vincent Morinière; Sandrine Marlin; Valérie Koubi; Heinz D Gabriel; Estelle Colin; Dominique Bonneau; Rémi Salomon; Corinne Antignac; Laurence Heidet
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

2.  Localization of MCM2-7, Cdc45, and GINS to the site of DNA unwinding during eukaryotic DNA replication.

Authors:  Marcin Pacek; Antonin V Tutter; Yumiko Kubota; Haruhiko Takisawa; Johannes C Walter
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

3.  Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation.

Authors:  P Billuart; T Bienvenu; N Ronce; V des Portes; M C Vinet; R Zemni; H Roest Crollius; A Carrié; F Fauchereau; M Cherry; S Briault; B Hamel; J P Fryns; C Beldjord; A Kahn; C Moraine; J Chelly
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

4.  Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances.

Authors:  S Solinas-Toldo; S Lampel; S Stilgenbauer; J Nickolenko; A Benner; H Döhner; T Cremer; P Lichter
Journal:  Genes Chromosomes Cancer       Date:  1997-12       Impact factor: 5.006

5.  Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization.

Authors:  Boris Zielinski; Sandrine Gratias; Grischa Toedt; Frank Mendrzyk; Daniel E Stange; Bernhard Radlwimmer; Dietmar R Lohmann; Peter Lichter
Journal:  Genes Chromosomes Cancer       Date:  2005-07       Impact factor: 5.006

6.  A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family.

Authors:  S Abdelhak; V Kalatzis; R Heilig; S Compain; D Samson; C Vincent; D Weil; C Cruaud; I Sahly; M Leibovici; M Bitner-Glindzicz; M Francis; D Lacombe; J Vigneron; R Charachon; K Boven; P Bedbeder; N Van Regemorter; J Weissenbach; C Petit
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

7.  Gender-specific growth patterns for stature, sitting height and limbs length in Croatian children and youth (3 to 18 years of age).

Authors:  Miroslav Zivicnjak; Nina Smolej Narancić; Lajos Szirovicza; Doris Franke; Jasna Hrenović; Vesna Bisof
Journal:  Coll Antropol       Date:  2003-06

8.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  Phenotypic heterogeneity of genomic disorders and rare copy-number variants.

Authors:  Santhosh Girirajan; Jill A Rosenfeld; Bradley P Coe; Sumit Parikh; Neil Friedman; Amy Goldstein; Robyn A Filipink; Juliann S McConnell; Brad Angle; Wendy S Meschino; Marjan M Nezarati; Alexander Asamoah; Kelly E Jackson; Gordon C Gowans; Judith A Martin; Erin P Carmany; David W Stockton; Rhonda E Schnur; Lynette S Penney; Donna M Martin; Salmo Raskin; Kathleen Leppig; Heidi Thiese; Rosemarie Smith; Erika Aberg; Dmitriy M Niyazov; Luis F Escobar; Dima El-Khechen; Kisha D Johnson; Robert R Lebel; Kiana Siefkas; Susie Ball; Natasha Shur; Marianne McGuire; Campbell K Brasington; J Edward Spence; Laura S Martin; Carol Clericuzio; Blake C Ballif; Lisa G Shaffer; Evan E Eichler
Journal:  N Engl J Med       Date:  2012-09-12       Impact factor: 91.245

10.  Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks.

Authors:  Heiko Fensterer; Bernhard Radlwimmer; Jörn Sträter; Malte Buchholz; Daniela E Aust; Catherine Julié; François Radvanyi; Bernard Nordlinger; Claudio Belluco; Eric Van Cutsem; Claus-Henning Köhne; Hans A Kestler; Carsten Schwaenen; Michelle Nessling; Manfred P Lutz; Peter Lichter; Thomas M Gress
Journal:  BMC Cancer       Date:  2007-04-02       Impact factor: 4.430

View more
  10 in total

1.  FIG4 variants in central European patients with amyotrophic lateral sclerosis: a whole-exome and targeted sequencing study.

Authors:  Alma Osmanovic; Isolde Rangnau; Anne Kosfeld; Susanne Abdulla; Claas Janssen; Bernd Auber; Peter Raab; Matthias Preller; Susanne Petri; Ruthild G Weber
Journal:  Eur J Hum Genet       Date:  2017-01-04       Impact factor: 4.246

2.  Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT).

Authors:  Anne Kosfeld; Martin Kreuzer; Christoph Daniel; Frank Brand; Anne-Kathrin Schäfer; Alexandra Chadt; Anna-Carina Weiss; Vera Riehmer; Cécile Jeanpierre; Michael Klintschar; Jan Hinrich Bräsen; Kerstin Amann; Lars Pape; Andreas Kispert; Hadi Al-Hasani; Dieter Haffner; Ruthild G Weber
Journal:  Hum Genet       Date:  2015-11-16       Impact factor: 4.132

3.  Exome sequencing identified new mutations in a Marfan syndrome family.

Authors:  Guangxin Li; Jian Yu; Kun Wang; Bin Wang; Minghai Wang; Shuguang Zhang; Shiyong Qin; Zhenhai Yu
Journal:  Diagn Pathol       Date:  2014-01-31       Impact factor: 2.644

4.  PGMD: a comprehensive manually curated pharmacogenomic database.

Authors:  A Kaplun; J D Hogan; F Schacherer; A P Peter; S Krishna; B R Braun; R Nambudiry; M G Nitu; R Mallelwar; A Albayrak
Journal:  Pharmacogenomics J       Date:  2015-05-05       Impact factor: 3.550

5.  Establishing and validating regulatory regions for variant annotation and expression analysis.

Authors:  Alexander Kaplun; Mathias Krull; Karthick Lakshman; Volker Matys; Birgit Lewicki; Jennifer D Hogan
Journal:  BMC Genomics       Date:  2016-06-23       Impact factor: 3.969

6.  Exome sequencing identifies pathogenic variants of VPS13B in a patient with familial 16p11.2 duplication.

Authors:  Jila Dastan; Chieko Chijiwa; Flamingo Tang; Sally Martell; Ying Qiao; Evica Rajcan-Separovic; M E Suzanne Lewis
Journal:  BMC Med Genet       Date:  2016-11-10       Impact factor: 2.103

7.  Copy number variant and runs of homozygosity detection by microarrays enabled more precise molecular diagnoses in 11,020 clinical exome cases.

Authors:  Avinash V Dharmadhikari; Rajarshi Ghosh; Bo Yuan; Pengfei Liu; Hongzheng Dai; Sami Al Masri; Jennifer Scull; Jennifer E Posey; Allen H Jiang; Weimin He; Francesco Vetrini; Alicia A Braxton; Patricia Ward; Theodore Chiang; Chunjing Qu; Shen Gu; Chad A Shaw; Janice L Smith; Seema Lalani; Pawel Stankiewicz; Sau-Wai Cheung; Carlos A Bacino; Ankita Patel; Amy M Breman; Xia Wang; Linyan Meng; Rui Xiao; Fan Xia; Donna Muzny; Richard A Gibbs; Arthur L Beaudet; Christine M Eng; James R Lupski; Yaping Yang; Weimin Bi
Journal:  Genome Med       Date:  2019-05-17       Impact factor: 11.117

8.  Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation.

Authors:  Liam S Carroll; Rebecca Woolf; Yousef Ibrahim; Hywel J Williams; Sarah Dwyer; James Walters; George Kirov; Michael C O'Donovan; Michael J Owen
Journal:  Psychiatr Genet       Date:  2016-04       Impact factor: 2.458

Review 9.  Prioritization of neurodevelopmental disease genes by discovery of new mutations.

Authors:  Alexander Hoischen; Niklas Krumm; Evan E Eichler
Journal:  Nat Neurosci       Date:  2014-05-27       Impact factor: 24.884

10.  Copy number variants (CNVs) analysis in a deeply phenotyped cohort of individuals with intellectual disability (ID).

Authors:  Ying Qiao; Eloi Mercier; Jila Dastan; Jane Hurlburt; Barbara McGillivray; Albert E Chudley; Sandra Farrell; Francois P Bernier; Me Suzanne Lewis; Paul Pavlidis; Evica Rajcan-Separovic
Journal:  BMC Med Genet       Date:  2014-07-16       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.